New Nodule-Newer Etiology

Table 1 Demographics of lung transplant recipients with pulmonary nodules

Patient	Sex	Age	Indication for LTX	Type of LTX	Anticoagulation
1	M	71	IPF/UIP	Right	Warfarin
2	F	42	COPD	Right
3	F	60	CB	Bil
4	F	54	PVOD	Bil	LMWH
5	M	62	COPD	Bil
6	M	69	IPF	Left
7	M	29	PVOD	Bil
8	F	50	ILD/MCTD/PSS	Bil
9	M	32	ILD/PSS with PHTN	Bil
10	M	31	CF	Bil

LTX: Lung transplantation; IPF: Idiopathic pulmonary fibrosis; COPD: Chronic obstructive pulmonary disease; CB: Constrictive bronchiolitis; PVOD: Pulmonary veno-occlusive disease; ILD: Interstitial lung disease; MCTD: Mixed connective tissue disease; PSS: Progressive systemic sclerosis; PHTN: Pulmonary hypertension; CF: Cystic fibrosis; LMWH: Low molecular weight heparin.

Table 2 Characteristics of the pulmonary nodules

FB	DOA	DOD	n	Size (cm)	Shape	Nature	Location
1	21	71	1	1.1	Round	Solid	RML
2	17	84	1	2.3	Round	Solid	RLL
3	16	12	2	1.2, 2.2	Round oval	Solid	RLL
4	13	60	2	1.1, 3	Round oval	Solid	RLL
5	27	25	2	1 × 0.7, 0.5 × 0.4	Oval	Solid	LUL, LLL
6	14	33	1	1 × 1.1	Oval	Solid	RML
7	4	9	1	1.5 × 2.5	Oval	Cavitary	LUL
8	21	33	1	1 × 1.1	Oval	Solid	LUL
9	10	19	1	2.2	Round	Solid	LLL
10	8	53	1	1.4 × 1.1	Oval	Cavitary	LUL
11	4	37	4	2, 2, 2, 1.2	Round	Cavitary	LUL, LLL 3
						Solid
12	28	48	1	0.4	Round	Cavitary	LLL
13	47	35	1	0.7	Round	Cavitary	RLL

FB: Flexible bronchoscopy; DOA: Day of appearance; DOD: Day of disappearance; RML: Right middle lobe; RLL: Right lower lobe; LUL: Left upper lobe; LLL: Left lower lobe.